According to reports, the passage of two bills within Michigan’s legislature – which will allow Blue Cross and Blue Shield of Michigan to convert itself into a nonprofit health insurer – could potentially negate some allegations currently standing against BCBS brought by the Department of Justice and Aetna Inc. claiming that the insurance company abused its dominance. Senate Bills 1293 and 1294 include a provision that would require BCBS of Michigan to stop enforcing “most favored nation” clauses in hospital contracts; In 2010 the DOJ brought charges against the health insurer claiming it forced 22 Michigan hospitals into “most favored nation-plus” contracts, which force the hospitals to charge higher prices to competing health insurers. The new legislation would also require Blue Cross to contribute a “fair share” of reimbursement to hospitals “to account for underfunded government programs and uncompensated care.” The new legislation could potentially mean some legal leniency in the insurer’s current antitrust cases with the DOJ and Aetna Inc., as the DOJ is only asking that Blue Cross stop using most-favored-nation clauses in contracts, a request that would be taken care of by new law.
Full Content: Crain’s Detroit Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC and State Attorneys General Sue John Deere Over Repair Restrictions in Antitrust Case
Jan 15, 2025 by
CPI
Enbridge Wins Legal Battle Against Ducere’s Antitrust Allegations
Jan 15, 2025 by
CPI
GOP Pushes for Antitrust Authority Consolidation Under DOJ in New Legislation
Jan 15, 2025 by
CPI
Canadian Government Approves Bunge-Viterra Merger with Conditions
Jan 15, 2025 by
CPI
SEC Sues Elon Musk Over Delayed Disclosure of Twitter Stock Ownership
Jan 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand